Ignite Creation Date:
2024-05-06 @ 3:48 AM
Last Modification Date:
2024-10-26 @ 11:39 AM
Study NCT ID:
NCT02377336
Status:
WITHDRAWN
Last Update Posted:
2015-06-08
First Post:
2015-02-26
Brief Title:
GS-6615 in Adults With Chronic Stable Angina and Coronary Artery Disease
Sponsor:
Gilead Sciences
Organization:
Gilead Sciences
Study Overview
Official Title:
A Phase 2 Randomized Double-Blind Placebo-Controlled Parallel Study of GS-6615 in Subjects With Chronic Stable Angina and Coronary Artery Disease
Status:
WITHDRAWN
Status Verified Date:
2015-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Anticipated recruitment challenges
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will evaluate the effect of GS-6615 in adults with chronic stable angina and coronary artery disease CAD receiving a stable daily dose of up to 2 antianginal medications The study will consist of two periods a 1 to 3 week Qualifying Period and a Treatment Period lasting 13 days 3 days During the Qualifying Period and at the end of the Treatment Period participants will undergo exercise tolerance testing
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2014-003994-41 | EUDRACT_NUMBER | None | None |